ArticleThe New England journal of medicine2011
HDL and cardiovascular-disease risk--time for a new approach?
Article in The New England journal of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies.European journal of preventive cardiology · 2016Pooled it
- Trial
- Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men.Steroids · 2012Trial
- Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.Circulation · 2024Article
- Flipped C-Terminal Ends of APOA1 Promote ABCA1-dependent Cholesterol Efflux by Small HDLs.medRxiv : the preprint server for health sciences · 2023Article
- Risk for Behçet's disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea.Scientific reports · 2022Article
- Gut Microbiota and Serum Metabolome in Elite Cross-Country Skiers: A Controlled Study.Metabolites · 2022Article
- HDL and Reverse Cholesterol Transport.Circulation research · 2019Review
- Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors.Journal of lipid research · 2017Article
- Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.Arteriosclerosis, thrombosis, and vascular biology · 2016Article
- High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.Arteriosclerosis, thrombosis, and vascular biology · 2012Review
- Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity.Journal of lipid research · 2012Article
- Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.Biochimica et biophysica acta · 2012Review
- Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein.Atherosclerosis · 2011Article
- Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway.Journal of proteomics · 2011Article
- Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Drug design, development and therapy · 2011Review
Corrections and comments
- Commented on by
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21226584What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.